|

ALN-BCAT Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Alnylam Pharmaceuticals1

Indications

  • Liver Disease1
  • Metastatic Hepatocellular Carcinoma1
  • Advanced Hepatocellular Carcinoma1
  • Liver Cancer1
  • Cancer1

Phoenix, Arizona1 trial

A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma

Clinical Trial Site

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.